ARCTURUS THERAPEUTICS HOLDINGS INC. Deferred Tax Liabilities, Gross
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) had Deferred Tax Liabilities, Gross of $5.17 million as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-03
- 2025-12-31: Deferred Tax Liabilities, Gross $5.17M.
- 2024-12-31: Deferred Tax Liabilities, Gross $7.03M.
- 2023-12-31: Deferred Tax Liabilities, Gross $8.01M.
- 2022-12-31: Deferred Tax Liabilities, Gross $8.30M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $5.17M 10-K · filed 2026-03-03 |
| 2024-12-31 | $7.03M 10-K · filed 2026-03-03 |
| 2023-12-31 | $8.01M 10-K · filed 2025-03-06 |
| 2022-12-31 | $8.30M 10-K · filed 2024-03-14 |
| 2021-12-31 | $1.26M 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |